Microvision
MVIS
144 hedge funds and large institutions have $179M invested in Microvision in 2022 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 13 closing their positions.
72% more call options, than puts
Call options by funds: $14.8M | Put options by funds: $8.59M
11% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 38
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
1% less funds holding
Funds holding: 145 → 144 (-1)
1.03% less ownership
Funds ownership: 31.03% → 30.01% (-1%)
9% less capital invested
Capital invested by funds: $197M → $179M (-$17.6M)
Top Buyers
Top Sellers
| 1 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$7.14M |
| 2 |
Morgan Stanley
New York
|
-$2.96M |
| 3 |
JP Morgan Chase
New York
|
-$1.77M |
| 4 |
AC
Aristides Capital
Louisville,
Kentucky
|
-$576K |
| 5 |
BlackRock
New York
|
-$381K |
MVIS Hedge Fund Activity: Q3 2022 in Review
144 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Microvision (MVIS) for Q3 2022, worth a combined $179M — down 9% from $197M a quarter earlier.
Fund positioning in MVIS was balanced in Q3 2022: 13 funds opened new positions, 13 closed out, 42 added to existing stakes and 38 trimmed.
The largest buyer was BNP Paribas Financial Markets, adding an estimated $1.74M. The largest seller was Mirae Asset Global Investments, cutting an estimated $7.14M.
- 144 institutional investors held Microvision (MVIS) as of Q3 2022, down from 145 in Q2 2022.
- Funds reported $179M of Microvision stock for Q3 2022, down 9% quarter-over-quarter.
- 13 funds opened new Microvision positions in Q3 2022 and 13 closed out, a net change of 0 holders.
- The largest Microvision buyer in Q3 2022 was BNP Paribas Financial Markets, an estimated $1.74M added.
- The largest Microvision seller in Q3 2022 was Mirae Asset Global Investments, an estimated $7.14M sold.
Based on aggregated 13F filings for Q3 2022.